Viohalco S.A. (VIO)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 15.22 |
|---|---|
| 52-week range | 7.98 – 22.80 |
| Return, 1 month / 3 months | −13.8% / −13.9% |
| Return, 1 year / 3 years | +92.5% / +229.8% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 53.5% |
| Worst drawdown (1 year) | -34.2% |
| Average daily value traded | 0.07M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Viohalco is a holding company for a group of metals processing and manufacturing businesses. Its subsidiaries make steel and aluminium products, copper and brass products, and cables, serving construction, industrial, energy and transport customers. The company is registered and based in Brussels, Belgium, while most of its operating plants and businesses are in Greece and other parts of Europe. It coordinates the activities of its subsidiary companies rather than running a single plant itself.
Viohalco S.A. trades under the code VIO on the Euronext Brussels in Belgium, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Viohalco S.A. (VIO) trades on the Euronext Brussels in Belgium. It last closed at EUR 15.22 on 22 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 75 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 92.5% and over the last three months it fell 13.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.8% | ||
| From 52-week high | -33.0% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -13.9% | ||
| 6-month return | 7.4% | ||
| 12-month return, skipping the last month | 123.3% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.2% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.07M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −13.8% |
| 3 months | −13.9% |
| 6 months | +7.4% |
| 1 year | +92.5% |
| 3 years | +229.8% |
| 5 years | +274.3% |
Signals
| 50-day / 200-day average | 16.72 / 16.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | EUR 0.1890 |
| 24 Jun 2025 | EUR 0.1120 |
| 25 Jun 2024 | EUR 0.0840 |
| 19 Jun 2023 | EUR 0.0840 |
| 3 Jun 2022 | EUR 0.0630 |
| 28 May 2021 | EUR 0.0140 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.